Skip to main content

Table 3 The pathological features, therapy and follow-up of these patients

From: Epidemiology, characteristics, and prognostic factors of lymphoplasmacyte-rich meningioma: a systematic literature review

Study

Year

Nb

Pathology

Surgery

Following-up time(months)

Recurrence

0utcome

Radiotherapy

EMA

CD3

CD20

CD138

CD38

LCA

Vimentin

S100

Ki67 + (%)

GFAP

PR

Wang,Y.B., et al. [25]

2018

1

1

 + 

 + 

 + 

 + 

    

3

 

-

GTR

24

No

ANT

NA

Yongjun, L., et al. [6]

2015

9

1

 + (9/9)

   

 + (9/9)

 + (9/9)

 + (9/9)

    

GTR

42

No

ANT

No(9/9)

  

2

           

GTR

34

No

ANT

 
  

3

           

STR

56

Yes(1 year)

ANT

 
  

4

           

GTR

23

No

ANT

 
  

5

           

GTR

34

No

ANT

 
  

6

           

STR

38

No

AWT

 
  

7

           

GTR

52

No

ANT

 
  

8

           

GTR

22

No

ANT

 
  

9

           

GTR

31

No

ANT

 

Tao, X., et al. [11](multicenter study without individual information)

2017

56

56

 + (23/24)

 + (13/14)

 + (12/12)

 

 + (13/14)

 + (12/12)

 + (18/19)

 + (10/12)

1–5(5/9)

3

 

GTR (45/56)

5–97

(average41.5)

3/56(at 36 months)

Died (1/56)

Yes(6/56)

   

-(1/24)

-(1/14)

  

-(1/14)

 

-(1/19)

-(2/12)

5–10(3/9)

5

 

STR (11/56)

5/56(at 60 months)

ANT at 36 months (52/56)

No(50/56)

           

 > 10(1/9)

     

ANT at 60 months (50/56)

 

de Almeida, G.B. and G. Januário [26]

2022

1

1

 + 

 + 

 + 

        

GTR

12

No

ANT

NA

Wang, H., et al. [7]

2021

1

1

 + 

 + 

 + 

 + 

 

 + 

  

 < 1

-

 + 

STR

  

Dead 2 weeks after operation for pneumonia

No

Gu, K.C., et al. [27]

2020

1

1

 + 

 + 

 + 

 + 

 + 

 + 

 + 

-

 < 5

-

-

GTR

36

No

ANT

No

Li, J., et al. [28]

2021

1

1

 + 

 + 

 + 

 + 

 

 + 

   

-

 + 

STR

3

No

AWT

No

Wang, Y.B., et al. [4]

2014

1

1

 + 

 + 

 + 

 + 

  

 + 

 

 + 

-

-

GTR

3

No

ANT

NA

Kanno, H., et al. [15]

2011

1

1

 + 

  

 + 

 

 + 

    

 + 

GTR

9

No

ANT

NA

Yang, X., et al. [29]

2018

1

1

 + 

  

 + 

       

STR

3

No

AWT

Yes

Avninder, S., V. Gupta, and K.C. Sharma [30]

2008

1

1

 + 

    

 + 

     

GTR

12

No

ANT

NA

Majumdar, K., et al. [31]

2013

1

1

 + 

 

 + 

  

 + 

 + 

 + 

   

GTR

9

No

ANT

NA

Zhu, H.D., et al. [8]

2013

19

1

 + (19/19)

    

 + (19/19)

 + (19/19)

  

-(most)

 

GTR

Lost follow-up

  

Yes(3/19)

  

2

           

GTR

63

No

ANT

No(16/19)

  

3

           

STR

59

No

AWT

 
  

4

           

GTR

Lost follow-up

   
  

5

           

GTR

50

No

ANT

 
  

6

           

GTR

50

No

ANT

 
  

7

           

GTR

50

No

ANT

 
  

8

           

GTR

49

No

ANT

 
  

9

           

STR

46

No

AWT

 
  

10

           

GTR

45

No

ANT

 
  

11

           

GTR

41

No

ANT

 
  

12

           

GTR

39

No

ANT

 
  

13

           

GTR

39

No

ANT

 
  

14

           

GTR

37

No

ANT

 
  

15

           

STR

33

No

AWT

 
  

16

           

GTR

32

No

ANT

 
  

17

           

GTR

31

No

ANT

 
  

18

           

GTR

28

No

ANT

 
  

19

           

GTR

24

No

ANT

 

Fukui, K., et al. [32]

2021

1

1

 + 

     

 + 

 

5

-

 

STR

12

Yes(at 12 months)

AWT

NA